G. Fachin

Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders.

A. Isacchi, G. Canevari, E. Felder, 2015, Bioorganic & medicinal chemistry.

4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors.

F. Fiorentini, M. Brasca, F. Roletto, 2010, Bioorganic & medicinal chemistry letters.

NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor.

F. Fiorentini, M. Brasca, E. Pesenti, 2011, Bioorganic & Medicinal Chemistry Letters.

Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships.

A. Isacchi, A. Montagnoli, N. Colombo, 2009, Journal of medicinal chemistry.

Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors.

D. Ballinari, V. Croci, D. Volpi, 2010, Journal of medicinal chemistry.

Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.

A. Isacchi, G. Canevari, E. Felder, 2014, Bioorganic & medicinal chemistry.

Defoliation percentage in two soybean cultivars at different growth stages

V. F. Guimarães, G. Fachin, A. C. T. D. Costa, 2015 .

Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.

A. Isacchi, G. Canevari, E. Felder, 2014, Bioorganic & medicinal chemistry.